Publications by authors named "J M Shefner"

Claim this Profile
P
Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trial.
Michal Geva, Y Paul Goldberg, Melanie L Leitner, Andres Cruz-Herranz, Randal Hand, Jeremy M Shefner

Amyotroph Lateral Scler Frontotemporal Degener· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospitalizations as an outcome measure in COURAGE-ALS.
Stacy A Rudnicki, Ammar Al-Chalabi, Jinsy A Andrews, Adriano Chio, Philippe Corcia, Jeremy M Shefner

Amyotroph Lateral Scler Frontotemporal Degener· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Participant, site personnel and sponsor perspectives on decentralized trial features in COURAGE-ALS: a randomized clinical trial.
Stacy A Rudnicki, Paulos Gebrehiwet, Stuart Kupfer, Fady I Malik, Lisa Meng, Jeremy M Shefner

Amyotroph Lateral Scler Frontotemporal Degener· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of the ENCALS predictive survival model in assessing the effect of the 24/44 inclusion criteria in FORTITUDE-ALS.
Tyrell Simkins Lead, Jeremy M Shefner, Stuart Kupfer, Fady I Malik, Lisa Meng

J Neuromuscul Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Operational Development and Launch of an Adaptive Platform Trial in Amyotrophic Lateral Sclerosis: Processes and Learnings From the First Four Regimens of the HEALEY ALS Platform Trial.
Brittney A Harkey, Sofia Distefano, Jaclyn A Pagliaro, Lindsay Heyd, Marianne Chase, Jeremy Shefner

Muscle Nerve· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis